Tags : Longevity

Pharma

Elevian’s Launch to Develop Medicines for Longevity and Age-Related Disorders

Shots: Elevian generated a seed funding of $5.5M from investors including WTI, Stanford StartX, Longevity Fund, Kizoo Ventures, Thynk Capital among others Its founders focus on regenerative effects of young blood and identified a specific circulating factor GDF11, by experimenting circulatory systems of young and old mice and observed regeneration of many tissues and organs […]Read More